Ligand validation:1VFX

ADP: ADENOSINE-5'-DIPHOSPHATE

ADP is a Ligand Of Interest in 1VFX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1VFX_ADP_A_500	49%	30%	0.203	0.951	1.23	1.55	3	5	5	0	100%	1
7EOB_ADP_A_500	92%	56%	0.088	0.978	0.83	0.86	-	-	0	0	100%	1
2ZFI_ADP_A_2000	81%	39%	0.109	0.96	1.24	1.14	4	2	0	0	100%	1
7EO9_ADP_A_401	74%	55%	0.142	0.972	0.78	0.97	-	2	2	0	100%	1
1I5S_ADP_A_2000	68%	7%	0.132	0.944	2.1	2.79	8	10	0	0	100%	1
2ZFL_ADP_A_2000	56%	36%	0.184	0.957	1.17	1.33	3	6	0	0	100%	1
3KB1_ADP_A_301	100%	22%	0.021	0.996	2.06	1.21	6	4	1	0	100%	1
5KHW_ADP_A_1201	100%	41%	0.023	0.995	1.1	1.2	1	2	0	0	100%	1
8VZA_ADP_A_603	100%	37%	0.024	0.995	0.96	1.51	1	5	0	0	100%	1
1PHP_ADP_A_396	100%	24%	0.026	0.995	1.29	1.8	3	11	1	0	100%	1
2QL6_ADP_M_301	100%	38%	0.029	0.996	1.08	1.33	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.